Pharmaceutical stocks can be excellent defensive investments during times of economic uncertainty, and many pharma stocks are ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

Both companies target serious health challenges, but their financials and risk profiles reveal sharply different paths for ...

The healthcare research specialist unveiled its first set of quarterly figures for 2026.

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...

The heart-drug developer sent a new signal to biotech investors about what Wall Street is willing to fund in 2026. That is ...

Italian healthcare vials and cartridges maker Stevanato Group and U.S. generic and wholesale pharmaceutical company Cencora ...

Eli Lilly became the first pharmaceutical company to top $1 trillion in market value in 2025. An aging population and improvements in technology are fueling the growth and promise of pharma stocks.

Takeda Pharmaceutical Company Limited (NYSE:TAK) is a Japanese pharmaceutical company. It is the largest pharmaceutical company in Asia by revenue. Its products include drugs and treatments for ...

Pharmaceutical stocks are making a comeback as valuations remain attractive and companies successfully address patent cliff concerns, according to UBS global head of biotech research Michael Yee. In ...

TheFly reported on June 8 that TEVA announced new clinical and real-world findings supporting the use of Austedo and Austedo ...

Johnson & Johnson is a global leader in the pharmaceutical and medical device industries. Its key products include anti-inflammation drug Stelara, multiple myeloma and light chain amyloidosis drug ...